Published in Klin Padiatr on November 01, 1977
Meningoencephalitis due to anthrax: CT and MR findings. Pediatr Radiol (2006) 0.84
Laboratory diagnosis and clinical significance of rubella in children with cancer. Epidemiol Infect (1989) 0.75
The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet (2000) 3.35
cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem (1994) 2.95
3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol (1996) 1.63
International gastroenterology research: subject areas, impact, and funding. Gut (2001) 1.60
Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Neuropediatrics (2007) 1.52
Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci U S A (1990) 1.33
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. J Pharmacol Exp Ther (1988) 1.32
Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. J Infect Dis (1971) 1.27
Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol (1999) 1.20
Evolution of catalytic and regulatory sites in phosphorylases. Nature (1985) 1.19
Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Anal Biochem (1995) 1.18
The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum. Aust J Exp Biol Med Sci (1971) 1.17
[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)]. Klin Padiatr (1981) 1.17
Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Eur J Clin Pharmacol (1985) 1.15
MR findings in pontocerebellar hypoplasia. Pediatr Radiol (1998) 1.14
The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase. EMBO J (1997) 1.14
Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol (2005) 1.13
Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr (2001) 1.12
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver (2001) 1.10
The separation of alpha- and beta-rabbit globin mRNA by polyacrylamide gel electrophoresis. FEBS Lett (1974) 1.09
Absence of transcallosal inhibition following focal magnetic stimulation in preschool children. Ann Neurol (1998) 1.08
Identification of seven novel mutations in the GAN gene. Hum Mutat (2003) 1.07
Escherichia coli maltodextrin phosphorylase: contribution of active site residues glutamate-637 and tyrosine-538 to the phosphorolytic cleavage of alpha-glucans. Biochemistry (1990) 1.07
Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy. Neurology (2003) 1.07
Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J Immunol (1998) 1.07
Differentiation of beta 1- and beta 2-adrenoceptor-mediated effects in humans. Am J Physiol (1988) 1.04
Oligosaccharide substrate binding in Escherichia coli maltodextrin phosphorylase. Nat Struct Biol (1997) 1.04
High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett (1999) 1.03
Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.99
Multisite contacts involved in coupling of the beta-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by beta-receptor-site-specific synthetic peptides. Eur J Biochem (1991) 0.99
High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia. Ann Neurol (1998) 0.97
Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. J Nucl Med (2000) 0.97
Enteroaggregative, Shiga toxin-producing Escherichia coli O104:H4 outbreak: new microbiological findings boost coordinated investigations by European public health laboratories. Euro Surveill (2011) 0.95
Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA). J Inherit Metab Dis (1996) 0.95
General acid-base catalysis of alpha-glucan phosphorylases: stereospecific glucosyl transfer from D-glucal is a pyridoxal 5'-phosphate and orthophosphate (arsenate) dependent reaction. Biochemistry (1982) 0.94
Congenital muscular dystrophy, brain malformation and ocular problems (muscle, eye and brain disease) in two German families. Eur J Pediatr (1984) 0.92
A syndrome of short stature, amimic facies, enamel hypoplasia, slowly progressive stiffness of the joints and high-pitched voice in two siblings. J Pediatr (1977) 0.92
Development of the corticospinal system and hand motor function: central conduction times and motor performance tests. Dev Med Child Neurol (2000) 0.91
Effects of Mg2+, Mn2+ and Ca2+ on adenylcyclase activity. Evidence for a metallic site. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.91
Identification and quantification of beta-adrenoceptors sites in red blood cells from rats. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.91
Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group. Neurology (2000) 0.91
Mechanism of the phosphorylase reaction. Utilization of D-gluco-hept-1-enitol in the absence of primer. Eur J Biochem (1986) 0.91
Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man. Eur J Clin Pharmacol (1993) 0.91
Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia (1994) 0.91
Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy. Clin Chem (2001) 0.90
Independent practitioner associations: improving the quality of health care. N Z Med J (1997) 0.90
The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains. Leukemia (2009) 0.90
Absence of transcallosal inhibition in adolescents with diplegic cerebral palsy. Muscle Nerve (1999) 0.90
N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke (1995) 0.89
[Influence of recurrent hypoglycemia on the EEG of the diabetic child]. Monatsschr Kinderheilkd (1969) 0.89
The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients. Ann Oncol (1996) 0.89
Chemical and functional analysis of components of adenylyl cyclase from human platelets treated with phorbolesters. FEBS Lett (1991) 0.89
[Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.89
Secretory antibodies against Giardia intestinalis in lactating Nicaraguan women. Parasite Immunol (2005) 0.88
Outcome and acute care hospital costs after warm water near drowning in children. Pediatrics (1997) 0.88
Fast corticospinal system and motor performance in children: conduction proceeds skill. Pediatr Neurol (1998) 0.88
Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Klin Padiatr (1998) 0.88
Direct determination of the sign of the NO dipole moment. Phys Rev Lett (2007) 0.88
[Catecholamines and other sympathomimetic amines. Biosynthesis and inactivation. Liberation and action]. Ergeb Physiol (1966) 0.88
Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas. Br J Haematol (2006) 0.87
Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Eur Heart J (1987) 0.87
A scanning tunneling microscope (STM) for biological applications: design and performance. Ultramicroscopy (1988) 0.87
Does pyridoxal 5'-phosphate function in glycogen phosphorylase as an electrophilic or a general acid catalyst? Biochemistry (1984) 0.87
CNS lipoma in patients with epidermal nevus syndrome. Neuropediatrics (2000) 0.87
Nosology of congenital non-progressive cerebellar ataxia. Report on six cases in three families. Neuropadiatrie (1974) 0.87
Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene. J Neurol Neurosurg Psychiatry (2003) 0.87
Dynamic responses to intravenous urapidil and dihydralazine in normal subjects. Clin Pharmacol Ther (1985) 0.86
Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers. Arzneimittelforschung (1985) 0.86
Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors. Klin Padiatr (2000) 0.86
Recruitment of the sensorimotor cortex--a developmental FMRI study. Neuropediatrics (2005) 0.85
Affinity and selectivity of beta-adrenoceptor antagonists in vitro. J Cardiovasc Pharmacol (1986) 0.85
Prospective 6 weeks follow-up post-cholecystectomy: the predictive value of pre-operative symptoms. J Gastrointest Surg (2008) 0.85
Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem (2000) 0.85
Primary rhabdomyosarcoma of the leptomeninx. Clinical, neuroradiological and pathological aspects. Clin Neurol Neurosurg (1984) 0.85
Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood (1989) 0.85
Low level of intracortical inhibition in children shown by transcranial magnetic stimulation. Neuropediatrics (2004) 0.85
Dissecting differential binding in the forward and reverse reaction of Escherichia coli maltodextrin phosphorylase using 2-deoxyglucosyl substrates. J Biol Chem (1994) 0.85
Amino-acid sequence of the pyridoxal-phosphate-binding site in Escherichia coli maltodextrin phosphorylase. Eur J Biochem (1978) 0.84
Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. J Neurol (2001) 0.84
Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013. Euro Surveill (2014) 0.84
Mutational analysis of the oligosaccharide recognition site at the active site of Escherichia coli maltodextrin phosphorylase. Biochemistry (1996) 0.84
Correlation between isoprenaline-stimulated synthesis of cyclic AMP and occurrence of beta-adrenoreceptors in immature erythrocytes from rats. Eur J Pharmacol (1978) 0.84
Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy. Eur J Clin Pharmacol (1986) 0.84
Lipoastrocytoma: a rare low-grade astrocytoma variant of pediatric age. Acta Neuropathol (2001) 0.84
Fetal antigen 1 (FA1) in the human pancreas: cell type expression, topological and quantitative variations during development. Anat Embryol (Berl) (1993) 0.84
Simultaneous measurement, using flow cytometry, of radiosensitivity and defective mitogen response in ataxia telangiectasia and related syndromes. Eur J Pediatr (1992) 0.84
Rare combination of Becker muscular dystrophy and Klinefelter's syndrome in one patient. Brain Dev (1997) 0.83
Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans. Clin Pharmacol Ther (1994) 0.83
[Quantitative parameters of sympatho-neuronal and sympatho-adrenal activities in man. The influence of beta-receptor blocking agents (author's transl)]. Arzneimittelforschung (1977) 0.83
Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Electro-encephalographic disturbances due to chronic toxin abuse in young people, with special reference to glue-sniffing. S Afr Med J (1990) 0.83
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay. J Cardiovasc Pharmacol (1986) 0.83
Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg (2001) 0.82
Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.82
E. coli maltodextrin phosphorylase: primary structure and deletion mapping of the C-terminal site. Z Naturforsch C (1987) 0.82
Ventriculomegaly diagnosed by prenatal ultrasound and mental development of the children. Fetal Diagn Ther (1998) 0.82
Noradrenaline depleting effect and metabolism of oxyfedrine in rats. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.82
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm Park Dis Dement Sect (1994) 0.82